Skip to main content
Clinical Trials/NL-OMON48345
NL-OMON48345
Completed
Not Applicable

Feasibility of a mobile application guiding patients with inflammatory bowel disease during biologic treatment - Mobile application for IBD patients with biologics

Rijnstate Ziekenhuis0 sites55 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Crohn's disease and ulcerative colitis
Sponsor
Rijnstate Ziekenhuis
Enrollment
55
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Rijnstate Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \- Diagnosis of inflammatory bowel disease (including Crohn\*s disease,
  • ulcerative colitis and IBD\-unclassified) based on a combination of clinical,
  • endoscopic, histologic and radiologic internationally accepted criteria.
  • \- Treatment with biologics, for the purpose of this study only patients with
  • biologics that are administered intravenously in the hospital every 4\-10 weeks
  • are included (infliximab or vedoluzimab).
  • \- Aged 18 years or older.
  • \- Having (access to) a tablet or smartphone.
  • \- Having (access to) working internet connection.
  • \- Ability to read and understand the Dutch language.

Exclusion Criteria

  • \- Patients recently started with biologic treatment (\< 3 maanden)
  • \- No access to a tablet or smartphone
  • \- No internet access

Outcomes

Primary Outcomes

Not specified

Similar Trials